We demonstrated previously that ginsenoside Rg 3 (Rg 3 ), an active ingredient of Panax ginseng, inhibits brain-type Na ϩ channel activity. In this study, we sought to elucidate the molecular mechanisms underlying Rg 3 -induced Na ϩ channel inhibition. We used the two-microelectrode voltage-clamp technique to investigate the effect of Rg 3 on Na ϩ currents (I Na ) in Xenopus laevis oocytes expressing wild-type rat brain Na V 1.2 ␣ and ␤1 subunits, or mutants in the channel entrance, the pore region, the lidocaine/tetrodotoxin (TTX) binding sites, the S4 voltage sensor segments of domains I to IV, and the Ile-PheMet inactivation cluster. In oocytes expressing wild-type Na ϩ channels, Rg 3 induced tonic and use-dependent inhibitions of peak I Na . The Rg 3 -induced tonic inhibition of I Na was voltagedependent, dose-dependent, and reversible, with an IC 50 value of 32 Ϯ 6 M. Rg 3 treatment produced a 11.2 Ϯ 3.5 mV depolarizing shift in the activation voltage but did not alter the steady-state inactivation voltage. Mutations in the channel entrance, pore region, lidocaine/TTX binding sites, or voltage sensor segments did not affect Rg 3 -induced tonic blockade of peak I Na . However, Rg 3 treatment inhibited the peak and plateau I Na in the IFMQ3 mutant, indicating that Rg 3 inhibits both the resting and open states of Na ϩ channel. Neutralization of the positive charge at position 859 of voltage sensor segment domain II abolished the Rg 3 -induced activation voltage shift and use-dependent inhibition. These results reveal that Rg 3 is a novel Na ϩ channel inhibitor capable of acting on the resting and open states of Na ϩ channel via interactions with the S4 voltage-sensor segment of domain II.
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Na
ϩ channels are transmembrane proteins that consist of a pore-forming ␣ subunit and auxiliary ␤1, ␤2, and ␤3 subunits (Catterall, 1987; Goldin, 1995; Wang et al., 2003) . The ␣ subunit is composed of four homologous domains (I-IV), each composed of six ␣-helical transmembrane segments (S1-S6). Among them, the S4 segment acts as the voltagesensing apparatus of the Na ϩ channel (Hodgkin and Huxley, 1952) . The pore-forming ␣ subunit is responsible for voltagedependent increases in Na ϩ -selective permeability. These changes trigger the inward Na ϩ current (I Na ), which initiates axonal and somatic action potentials in nerve and muscle fibers and may also be involved in axonal information transfer for intraneuronal or interneuronal communications (Hodgkin and Huxley, 1952; Stuart and Sakmann, 1994) . Na ϩ channels can exist in resting (closed), open (active), or inactivated states and transition among the various states in response to time-and voltage-dependent signaling (Hodgkin and Huxley, 1952) . Various drugs can exhibit differential affinities to the specific Na ϩ channel states. For example, lidocaine (a local anesthetic) and phenytoin (an anticonvulsant) show a low affinity for the resting state and a higher affinity for the inactivated state, whereas flecainide (an an-tiarrhythmic drug) inhibits the open state (Bean et al., 1983; Hondegham and Kazung, 1984) . Na ϩ channel modulators that act as drugs and/or neurotoxins often affect both permeation and gating properties (Goldin, 1995) , and site-directed mutagenesis studies have allowed characterization of the detailed action and binding sites of various drugs and toxins that regulate neuronal Na ϩ channel activity (Catterall, 1987; Goldin, 1995; Wang et al., 2004) .
Ginseng, the root of Panax ginseng C.A. Meyer, is well known in herbal medicine as a tonic and restorative agent. The main molecular ingredients responsible for the actions of ginseng are the ginsenosides (also called ginseng saponins), which are amphiphilic molecules comprising a hydrophobic backbone of aglycone (a hydrophobic, four-ring, steroid-like structure) linked to hydrophilic carbohydrate side chains consisting of monomers, dimers, or tetramers (Fig. 1) . The ginsenosides are classified as protopanaxadiol or protopanaxatriol, according to the positions of the carbohydrate moieties at carbons -3, -6, and -20, which can be either free or connected to sugar rings (Nah, 1997) . We recently demonstrated that ginsenoside Rg 3 (20-S-protopanaxadiol-3-[O-␤-D-glucopyranosyl (132)-␤-glucopyranoside]) (Rg 3 ), one of the active ingredients in Panax ginseng, inhibits voltage-dependent brain Na ϩ channel activity expressed in Xenopus laevis oocytes (Jeong et al., 2004; Kim et al., 2005) . However, no previous work has examined the underlying mechanisms by which Rg 3 regulates Na ϩ channel currents. We herein sought to characterize ginsenoside-mediated Na ϩ channel regulation in an X. laevis oocyte gene expression system. This model system has few endogenous ion channels (Dascal, 1987) and allows heterologous expression of ion channels for various biochemical studies (Choi et al., , 2003 Sala et al., 2002) . We expressed brain Na ϩ channels by intraoocyte injection of cRNAs encoding the Na V 1.2 ␣ and ␤1 subunits (Pugsley and Goldin, 1998; Pugsley et al., 2000) with or without various mutations and examined the changes in I Na in response to Rg 3 treatment. We found that Rg 3 caused both tonic and use-dependent inhibitions of the peak I Na after low-and high-frequency stimulations. We further found that mutations in the channel pore entrance, pore region, lidocaine binding sites, tetrodotoxin (TTX) binding sites, and S4 voltage sensor segments of domains I-IV of the Na ϩ channel had no effect on Rg 3 -induced tonic inhibition of peak I Na . However, when inactivation cluster Ile1488-Phe1489-Met1490 was mutated to I1488Q-F1489Q-M1490Q (IFMQ3) (West et al., 1992) to create an inactivation-deficient mutant, Rg 3 treatment inhibited both the peak and noninactivating plateau I Na levels of this mutant, indicating that Rg 3 regulates the resting and open states of the expressed Na ϩ channel. A single Lys-to-Gln mutation at residue 859 (K859Q) within the S4 voltage sensor segment of domain II abolished the Rg 3 -induced shift of the activation voltage and use-dependent inhibition, although changes in the other domains did not. Taken together, these results show for the first time that Rg 3 acts as a novel Na ϩ channel blocker by interacting with the S4 voltage-sensor segment of domain II.
Experimental Procedures
Materials. The 20(S)-ginsenoside Rg 3 (Fig. 1) was kindly provided by the Korean Ginseng Cooperation (Taejon, Korea). The cDNA for the rat brain Na ϩ channel Na V 1.2 ␣ subunit was kindly provided by Dr. A. L. Goldin (University of California, Irvine, CA) and that for the Na ϩ channel ␤1 subunit was kindly provided by Dr. T. Zimmer (Friedrich Schiller University, Jena, Germany). Other agents were purchased from Sigma (St. Louis, MO).
Preparation of X. laevis Oocytes and Microinjection. X. laevis frogs were purchased from Xenopus I (Ann Arbor, MI). Their care and handling was in accordance with the highest standards of institutional guidelines. For isolation of oocytes, frogs were anesthetized with an aerated solution of 3-amino benzoic acid ethyl ester, and ovarian follicles were removed. The oocytes were separated by treatment with collagenase and agitation for 2 h in Ca 2ϩ -free medium containing 82.5 mM NaCl, 2 mM KCl, 1 mM MgCl 2 , 5 mM HEPES, 2.5 mM sodium pyruvate, 100 units/ml penicillin, and 100 g/ml streptomycin. Stage V-VI oocytes were collected and stored in ND96 (96 mM NaCl, 2 mM KCl, 1 mM MgCl 2 , 1.8 mM CaCl 2 , and 5 mM HEPES, pH 7.5) supplemented with 0.5 mM theophylline and 50 g/ml gentamicin. This oocyte-containing solution was maintained at 18°C with continuous gentle shaking and was renewed everyday. Electrophysiological experiments were performed within 5 to 6 days of oocyte isolation, with chemicals applied to the bath. For Na ϩ channel experiments, 40 nl of cRNAs encoding the Na V 1.2 ␣ and ␤1 subunits was injected into the animal or vegetal pole of each oocyte one day after isolation, using a 10-l VWR microdispenser (VWR Scientific, San Francisco, CA) fitted with a tapered glass pipette tip (15-20 m in diameter; Choi et al., 2003) .
Site-Directed Mutagenesis of Na V 1.2 and in Vitro Transcription of Na ؉ Channel Subunit cDNAs. The substitution mutations of single or triplet amino acids were performed using the QuikChange XL site-directed mutagenesis kit (Stratagene, La jolla, CA), along with Pfu DNA polymerase and mutated sense and antisense primers. Overlap extension of the target domain by sequential polymerase chain reactions was carried out according to the manufacturer's recommended protocol. The final PCR products were transformed to Escherichia coli strain DH5␣, screened by PCR and confirmed by DNA sequencing of the target region. The mutant DNA constructs were linearized at the 3Ј end by NotI digestion, and run-off transcripts were prepared using methylated cap analog m 7 G(5Ј)ppp(5Ј)G. The cRNAs were prepared using the mMessage mMachine transcription kit (Ambion, Austin, TX) with T7 RNA polymerase. The absence of degraded RNA was determined by denaturing agarose gel electrophoresis followed by ethidium bromide staining. Likewise, recombinant plasmids containing wild-type Na V 1.2 ␣ or ␤1 subunit cDNA inserts were linearized by digestion with the appropriate restriction enzymes, and cRNAs were obtained using the mMessage mMachine in vitro transcription kit (Ambion) with SP6 RNA or T7 polymerases. The final cRNA products were resuspended at a concentration of 1 g/l in RNase-free water and stored at Ϫ80°C until use (Choi et al., 2003) .
Data Recording. A custom-made Plexiglas net chamber was used for two-electrode voltage-clamp recordings. The chamber was constructed by milling two concentric wells into the chamber bottom Ginsenoside Rg 3 Blocks Brain Na ؉ Channels (the diameter and height of the upper well were 8 and 3 mm, respectively, and those of the lower well were 6 and 5 mm, respectively) and gluing plastic meshes (ϳ0.4-mm grid diameter) onto the bottom of the upper well. A perfusion inlet (ϳ1 mm in diameter) was drilled through the wall of the lower well, and a suction tube was placed on the edge of the upper well. For experiments, a single oocyte was placed on the net separating the upper and lower wells. The net grids helped anchor the oocyte in place during the electrophysiological recordings. The oocyte was then impaled with two microelectrodes filled with 3 M KCl (0.2-0.7 M⍀) and electrophysiological experiments were carried out at room temperature using an oocyte clamp (Warner Instruments, Hamden, CT). Stimulation and data acquisition were controlled with a pClamp 8 (Axon Instruments, Union City, CA) (Choi et al., 2003) . For most of the electrophysiological experiments on Na ϩ channel activity, oocytes were clamped at a holding potential of Ϫ100 mV and the membrane potential was depolarized to Ϫ10 mV for 100 ms every 5 s. Linear leak currents were corrected by means of the leak subtraction procedure (Jeong et al., 2005) .
The voltage-dependence of Na ϩ channel activation was calculated by measuring the peak current at test potentials ranging from Ϫ50 mV to ϩ50 mV evoked in 5-mV increments. The conductance (g Na ) was calculated according to the equation, g Na ϭ I Na /(V g Ϫ V r ), where I Na is the peak amplitude of the Na ϩ current, V g is the test potential, and V r is the reversal potential for Na ϩ . The conductance-voltage curves were drawn according to the equation g Na/ g Na max ϭ 1/{1ϩ exp [(V g0.5 Ϫ V g )/kg]}, where g Na max is the maximum value for g Na , V g0.5 is the potential at which g Na is 0.5 g Na max , and kg is the slope factor (potential required for an e-fold change). The voltage-dependence of Na ϩ channel inactivation was determined using 200 ms conditioning prepulses ranging from Ϫ60 mV to ϩ20 mV from a holding potential of Ϫ100 mV in 5-mV increments, followed by a test pulse to Ϫ10 mV for 5 ms. The peak I Na was normalized to its respective maximum value (I Na max ) and plotted as a function of the prepulse potential. The steady-state inactivation curves were drawn according to the equation I Na /I Na max ϭ 1/{1 ϩ exp [(V h Ϫ V h0.5 )/kh]}, where V h is the prepulse potential, V h0.5 is the potential at which I Na is 0.5 I Na max , and kh is the slope factor.
The frequency-dependent effect of Rg 3 was examined using a protocol in which 50 depolarizing pulses of 10-ms duration and 10 Hz frequency were applied to Ϫ10 mV from a holding potential of Ϫ100 mV. The protocol was run in the absence (control) and presence of 10 or 100 M Rg 3 . The current amplitude of each pulse was normalized to the peak maximal current (pulse number 1) and plotted as a function of pulse number.
The kinetics of the Rg 3 blockade of IFMQ3, which is the fastinactivation-deficient mutant of Na V 1.2, were examined by clamping oocytes at Ϫ100 mV in ND96 solution. A single 500-ms depolarizing pulse to Ϫ10 mV was applied, and the I Na was recorded. Different concentrations of Rg 3 (10, 30, 100, or 300 M) were perfused into the bath for 1 min, and a second, single depolarizing pulse from Ϫ100 to Ϫ10 mV was given. The data were individually fit to either a single (Lansman et al., 1986) . Recovery from open channel blockade was measured at a holding potential of Ϫ100 mV with a 10-ms depolarizing prepulse to Ϫ10 mV (P1) followed by a variable recovery period from 10 to 500 ms, subsequently followed by a 10-ms test pulse to Ϫ10 mV (P2).
Data Analysis. To obtain the concentration-response curve of the effect of Rg 3 on I Na , the peak amplitudes at different concentrations of Rg 3 were plotted and then fitted to the following Hill equation using the Origin software (OriginLab Corp, Northampton, MA):
, where y is the peak I Na at given concentration of Rg 3 , y max is the maximal peak I Na , EC 50 is the concentration of Rg 3 producing a half-maximum effect, [A] is the concentration of Rg 3 , and n H is the interaction coefficient. All values are presented as means Ϯ S.E.M. The differences between the means of control and treatment values were determined using an unpaired Student's t test. A value of P Ͻ 0.05 was considered statistically significant.
Results
The Effect of Rg 3 on Peak I Na in Oocytes Expressing Na V 1.2. The effect of Rg 3 on currents from brain Na ϩ channels expressed in X. laevis oocytes was examined. I Na was recorded by two-electrode voltage clamping of oocytes injected with cRNAs encoding Na V 1.2 ␣ and ␤1 subunits. Oocytes were held at Ϫ100 mV, and I Na was elicited by depolarization to Ϫ10 mV at a low frequency (0.2 Hz). This procedure minimized the use-dependent blockade and allowed evaluation of whether Rg 3 produced a tonic blockade of peak I Na (Pugsley and Goldin, 1998; Pugsley et al., 2000) . For comparison, we also examined the effect of lidocaine on the peak I Na . As shown in Fig. 2A , the depolarizing voltage step induced a large inward I Na with rapid inactivation. Application of Rg 3 (100 M) or lidocaine (1000 M) inhibited the peak I Na by 64 Ϯ 7 and 41 Ϯ 10%, respectively ( Fig. 2A , inset), indicating that both agents induced a tonic inhibition of the Na ϩ current. Concentration-Dependent Inhibition of I Na by Rg 3 or Lidocaine. The current-voltage relationships were assessed in the absence or presence of Rg 3 with voltage steps ranging from Ϫ50 to ϩ50 mV evoked from a holding potential of Ϫ100 mV every 5 s. As shown in Fig. 2B , addition of Rg 3 caused a voltage-dependent reduction in peak I Na , with a more pronounced reduction noted at lower voltage ranges. In addition, Rg 3 treatment shifted the threshold voltage of channel opening and the voltage of the peak I Na to more depolarized values compared with the control. However, Rg 3 had no significant effect on the kinetics of current decay. As shown in Fig. 2C , the inhibitory effect of Rg 3 on peak I Na was dosedependent up to 300 M, with an estimated IC 50 value of 32 Ϯ 6 ⌴. The Hill coefficient was 1.1 Ϯ 0.4, indicating that one molecule of Rg 3 seemed sufficient to block one Na ϩ channel. We also tested the effect of lidocaine on peak I Na and found that it was dose-dependent up to 3000 M (Fig. 2C ). The IC 50 was 966 Ϯ 37 ⌴, which is consistent with previous report (Pugsley and Goldin, 1998) . These findings indicate that Rg 3 was more potent than lidocaine by approximately33.2-fold. It is noteworthy that the IC 50 value for Rg 3 -mediated Na ϩ current inhibition was 2-fold higher than that for Rg 3 -induced inhibition of Na ϩ influxes triggered by acetylcholine treatment in bovine adrenal chromaffin cells (Tachikawa et al., 1995) and 8-fold higher than that for Rg 3 -induced inhibition in [Ca 2ϩ ] i increase by NMDA treatment in rat hippocampal neurons (Kim et al., 2002) . These discrepancies in IC 50 values might reflect the differential affinity of Rg 3 for ion channels or receptors, suggesting that NMDA or nicotinic acetylcholine receptors might be more sensitive than Na ϩ channels to low concentrations of Rg 3 . The Effects of Rg 3 on the Activation and Inactivation of Na V 1.2. We next examined the effects of Rg 3 on the voltage-dependence of Na ϩ channel steady-state activation and inactivation. First, the effect of Rg 3 on Na ϩ channel activation was determined by a conductance transformation of the peak current-voltage relationship (Fig. 3, A and B) , with the curves representing the best data fit using the Boltzmann function. There was a significant depolarizing shift of the half-maximal activation voltage (V g0.5 ). The V g0.5 was Ϫ28.9 Ϯ 0.57 mV in control experiments and Ϫ17.8 Ϯ 0.21 mV in Rg 3 -treated oocytes (P Ͻ 0.01, compared with control, n ϭ 10). However, the slope factor (kg) was not significantly different, yielding values of 4.6 Ϯ 0.5 mV under control conditions and 4.8 Ϯ 0.2 mV after Rg 3 treatment. We then investigated the effect of Rg 3 on voltage-dependent Na ϩ channel inactivation by plotting the normalized peak I Na against the conditioning prepulse voltage (Fig. 3, C and D) and then fitting the data to the Boltzmann function. There was no significant difference in the half-maximal inactivation voltage (V h0.5 ) and the slope factor (kh) between control and Rg 3 treatment groups; V h0.5 was Ϫ28.9 Ϯ 0.57 and Ϫ26.9 Ϯ 0.68 mV, respectively, and kh was 7.2 Ϯ 0.4 and 8.1 Ϯ 0.68 mV, respectively (n ϭ 10). These findings indicate that Rg 3 affects the steady-state activation but not inactivation of the Na ϩ channel. Use-Dependent Blockade of Na V 1.2 by Rg 3 and Lidocaine. Because Na ϩ channel blockers such as lidocaine and other antiarrhythmic drugs exhibit use-dependent inhibition (Hondegham and Kazung, 1984) , we tested whether Rg 3 behaved in the same way, using Rg 3 concentrations shown to induce minimal I Na blockade (10 M) and marked I Na blockade (100 M) in our initial tonic block experiments. I Na was elicited by 20-ms pulses from Ϫ100 to Ϫ10 mV for 50 times at 10 Hz. Each peak I Na was normalized to the first pulse peak I Na . Under control conditions, there was a slight reduction in peak I Na , whereas treatment with 10 and 100 M Rg 3 induced use-dependent inhibitions of peak I Na values by 11 Ϯ 1 and 15 Ϯ 2%, respectively (n ϭ 9 each; Fig. 4A ). Lidocaine (1000 M) treatment also induced a use-dependent inhibition Fig. 2 . Tonic inhibition of I Na by Rg 3 and lidocaine. A, oocytes were injected with wild-type Na V 1.2 ␣ and ␤1 subunit cRNAs and maintained for 2 to 4 days before Na ϩ currents (I Na ) were recorded in ND96 using the two-electrode voltage clamp technique. E, peak inward current amplitudes elicited by 100-ms depolarizations to Ϫ10 mV from a holding potential of Ϫ100 mV, evoked every 5 s. Rg 3 (100 M) or lidocaine (1000 M) were applied during the period indicated by the solid bars. Inset, left, traces are representatives of six separate oocytes from three different frogs. Inset, right, the histograms show the percentage blockade of peak I Na by Rg 3 or lidocaine (Lido). Data represent the means Ϯ S.E.M. (n ϭ 10 -13/group). B, the current-voltage relationship was obtained using voltage steps between Ϫ50 and ϩ50 mV taken in 5-mV increments. Voltage steps were applied in the absence (F) and presence (E) of 100 M Rg 3 or after washout of Rg 3 (). Data represent the means Ϯ S.E.M. (n ϭ 5-6/group). C and D, concentration-response curves for the Rg 3 -(C) or lidocaine-(D) induced inhibition of peak I Na . Inset, traces are representatives of six separate oocytes from three different frogs. The solid lines were fit by the Hill equation as described under Experimental Procedures. Data represent the means Ϯ S.E.M. (n ϭ 10 -13/group).
Ginsenoside Rg 3 Blocks Brain Na ؉ Channels of the peak I Na by 35 Ϯ 2% (n ϭ 8 each) (Fig. 4A) . Thus, Rg 3 and lidocaine both seemed to induce use-dependent inhibitions of I Na . The Effect of Rg 3 on Peak I Na at Different Holding Potentials. The effect of Rg 3 on peak I Na at different holding potentials was examined. Diphenylhydantoin (DPH), which is a well known anticonvulsant that preferentially binds to the inactivated Na ϩ channel (Valenzuela et al., 1996) , did not significantly affect the peak I Na evoked at Ϫ10 mV from a holding potential of Ϫ110 mV (6 Ϯ 1% inhibition by 100 M, n ϭ 10) (Fig. 5A) . However, at a more depolarized holding potential of Ϫ50 mV, DPH dramatically reduced the peak I Na (86 Ϯ 7% inhibition by 100 M, n ϭ 10). This indicates that the blockade of peak I Na by DPH is highly sensitive to the membrane potential and that DPH has a much higher affinity to the inactivated state than to the resting state of the Na ϩ channel as shown by Kuo and Bean (1994) (Fig. 5 , A and C, left). We then tested the effect of Rg 3 on the peak I Na at different holding potentials. In contrast to the action of DPH, the inhibitory effect of 100 M Rg 3 was not significantly affected by changes in the holding potential (78 Ϯ 14% and 69 Ϯ 10% inhibition at Ϫ110 and Ϫ50 mV, respectively; n ϭ 15 each), indicating that the inhibitory effect of Rg 3 on the peak I Na is independent of the membrane holding potential (Fig. 5, B and C, right) .
Lidocaine and TTX Do Not Prevent Rg 3 -Induced Inhibition of Peak I Na . We performed occlusion experiments using lidocaine and TTX, which are well known Na ϩ channel blockers, to determine whether Rg 3 shares a common binding site or pathway with lidocaine or TTX. As shown in Figs. 6B and D, single applications of 30 M Rg 3 , 1000 M lidocaine and 1 nM TTX inhibited the peak I Na values by 42 Ϯ 8, 25 Ϯ 5, and 44 Ϯ 3%, respectively. Cotreatment of Rg 3 with lidocaine produced an additive inhibition of peak I Na by 88 Ϯ 4%, whereas cotreatment of Rg 3 with TTX produced an additive inhibition of peak I Na by 80 Ϯ 4%. These results suggest that Rg 3 regulates Na ϩ channels by acting on different site(s) from those of lidocaine and TTX.
The Effect of Rg 3 on Mutant Na ؉ Channels. To gain insight into the mechanism(s) by which Rg 3 inhibits peak Fig. 3 . The effect of Rg 3 on steady-state activation and inactivation of I Na in wild-type and K859Q mutant channels. A, effect of Rg 3 on steady-state activation and inactivation of I Na in wild-type channels. The voltage dependence of conductance was compared in the absence (F) and presence (E) of 100 M Rg 3 . Inactivation was measured using a two-pulse protocol in which oocytes were held at Ϫ100 mV and depolarized to potentials from Ϫ60 to ϩ20 mV for 200 ms, followed by a test-pulse to Ϫ10 mV for 10 ms to determine channel availability. Inactivation curves are shown in the absence (f) and presence of 100 M Rg 3 (Ⅺ). B, representative current traces for the activation and inactivation of wild-type channels were obtained as described under Experimental Procedures. The indicated traces are presented for clarity. C, the effect of Rg 3 on the steady-state activation and inactivation of I Na in the K859Q mutant. D, representative current traces for the activation and inactivation of the K859Q mutant channel were obtained as described. I Na , we examined the requirement of different Na ϩ channel ␣ subunit protein domains using site-directed mutagenesis. We constructed the following six mutant types: 1) mutation of the channel pore entrance of the S6 segment of domain I by replacement of residue Tyr401 with cysteine (Y401C) or threonine (Y401T); 2) mutation at the channel pore sites by replacement of Glu942 with glutamine (E942Q), Glu945 with glutamine (E945Q), or Asp927 with asparagine (D927N) (Kontis and Goldin, 1993) ; 3) mutation of the lidocaine binding sites by replacement of residues Phe1764 and/or Tyr1771 with alanine (F1764A or Y1771A and F1764A-Y1771A, respectively) (Ragsdale et al., 1994; ; 4) mutation of the extracellular and intracellular TTX binding sites by replacement of Phe385 with cysteine (F385C), serine (F385S), tyrosine (F385Y), or methionine (F385M), or replacement F387 with glycine (F387G), threonine (F387T) or glutamine (F387Q) (Noda et al., 1989; Terlau et al., 1991) ; 5) mutation of the S4 voltage-sensor segments of domains I to IV by replacement of residues Lys226, Lys859, Arg1312, or Arg1638 with glutamine (K226Q, K859Q, R1312Q, or R1638Q) (Kontis et al., 1997) ; and 6) creation of a fast inactivation gating-deficient mutant (IFMQ3) (West et al., 1992) . Representative traces were obtained from oocytes expressing channel pore, TTX binding site, and voltage-sensor mutants in the absence or presence of Rg 3 (Fig. 7A) . Rg 3 treatment induced tonic inhibition of the peak I Na in all mutants ( Fig. 7 and Table 1 ). The concentration-response relationship for peak I Na inhibition by Rg 3 in the different kinds of mutants was determined (Fig. 7B) , and the data were fitted using the Hill equation. The Hill coefficients and V max values for the mutants were not significantly different from those of the wild-type channels. However, the IC 50 values from mutants F385M, E387Q, Y401C, and K859Q were significantly higher than that of the wild-type channel (*, P Ͻ 0.01 compared with wild-type channel) (Table 1) . Because mutations of Phe1764 or Tyr1771 to alanine (F1764A or Y1771A) are resistant to lidocaine-induced tonic and use-dependent blockades (Ragsdale et al., 1994 (Ragsdale et al., , 1996 , we examined whether these mutations could affect the Rg 3 -mediated tonic and use-dependent inhibitions of peak I Na . Although lidocaine treatment induced only a slight inhibition of peak I Na in oocytes expressing the F1764A, Y1771A, and F1764A-Y1771A mutants after low-and high-frequency stimulations (Fig. 8, A, C , and E, low-frequency stimulations; B, D, and F, high-frequency stimulations), Rg 3 treatment induced wild-type inhibition levels of peak I Na in the mutants after in both low-and high-frequency stimulations (Fig. 8) . The IFMQ3 mutant, which lacks fast inactivation, showed a slower decay and a sizable persistent noninactivating or plateau current at the end of a 500-ms depolarizing pulse to Ϫ10 mV in the absence of Rg 3 , which is consistent with a previous report (West et al., 1992) . In the IFMQ3 mutant, Rg 3 treatment induced dosedependent inhibitions of peak and plateau I Na (Fig. 9A) . The plateau I Na showed a larger change; the IC 50 values of Rg 3 acting on the on peak and plateau I Na in this mutant were 38 Ϯ 3 and 14 Ϯ 4 M, respectively (approximately a 3-fold difference). These results suggest that Rg 3 interacts more readily with the open state of the Na ϩ channel versus the resting state (Fig. 9B) . Finally, we examined whether the IFMQ3 mutant showed any changes in the inhibitory effect of Fig. 4 . Use-dependent block of Na ϩ channels by Rg 3 or lidocaine. Fifty 20-ms depolarizing pulses to Ϫ10 mV were applied from a holding potential of Ϫ100 mV at 10 Hz in the absence (F) or presence of 10 M (E) or 100 M () Rg 3 in wild-type (A), IFMQ3 (B), K859Q (C), and IFMQ3-K859Q (D) mutants. Lidocaine (1000 M) (Ⅺ) was also applied in wild-type (A) and the K859Q mutant (C). The current amplitude during each pulse was normalized to the peak current of the first pulse and plotted as a function of the pulse number. Inset, only sweeps 1 and 50 are shown for both control and Rg 3 treatment groups in the wildtype and mutants (IFMQ3, K859Q, and IFMQ3-K859Q). The other sweeps were omitted for clarity. Data represent the means Ϯ S.E.M. (n ϭ 9 -10/group).
Ginsenoside Rg 3 Blocks Brain Na
؉ Channels Rg 3 on oocytes subjected to high-frequency stimulation. We observed that Rg 3 treatment induced a 2-to 3-fold larger use-dependent inhibition in IFMQ3 mutant channels versus wild-type channels; 10 and 100 M Rg 3 induced 17 Ϯ 1 and 45 Ϯ 4% use-dependent inhibitions of I Na , respectively (n ϭ 11) (Fig. 4, A Fig. 3 , A and B, Rg 3 treatment strongly depolarized the Na ϩ channel activation voltage, suggesting that Rg 3 might modify its activation gating. The S4 segments comprise four homologous domains (I-IV) of the Na ϩ channel and are believed to act as the voltage-sensing apparatus (Kontis et al., 1997) . To investigate whether mutations in the voltage-sensor segments of the Na ϩ channel affect the Rg 3 -induced depolarization of the Na ϩ channel activation voltage, we constructed four different mutants in the S4 segments of domain I to IV (Table 1) (Kontis et al., 1997) and examined their influences on the Rg 3 -induced voltage shift of the Na ϩ channel activation curve. Our results revealed that replacing Lys859 (domain II) with glutamine (K859Q) abolished the Rg 3 -induced voltage shift, although the mutation itself resulted in a depolarizing shift of the activation curve by ϳ10 mV compared with wild-type channel (Fig. 3, C and D) . The half-maximal activation voltage (Vg 0.5 ) was Ϫ10.9 Ϯ 0.4 mV and the slope factor (kg) was 5.1 Ϯ 0.3 mV in the Rg 3 control, but only Ϫ9.8 Ϯ 0.4 mV and 5.3 Ϯ 0.4 mV in the mutant (Fig. 3, C and  D) . The other tested mutants did not show significant alterations of the activation curve (data not shown), indicating that the Lys859 residue of domain II may play an important role in the Rg 3 -induced modification of voltage-dependent Na ϩ channel activation. A Single Point Mutation in the S4 Voltage-Sensor Segment of Domain II of Na V 1.2 in Both Wild-Type and IFMQ3 Mutant Channels Abolishes Rg 3 -Induced UseDependent Inhibition. We next examined whether the K859Q mutation affects the Rg 3 -induced use-dependent inhibition of Na ϩ channels, because this mutation abolished Rg 3 -induced modification of Na ϩ channel activation gating. Rg 3 treatment did not produce use-dependent inhibition in either K859Q or IFMQ3-K859Q mutants (Fig. 4, C and D) , suggesting that the Lys859 residue of the S4 voltage sensor Fig. 5 . Rg 3 -induced I Na inhibition is independent of the holding potential. A, representative traces of I Na in the absence or presence of 30 or 100 M phenytoin (DPH). Each oocyte was held at Ϫ50 or Ϫ100 mV and stepped to Ϫ10 mV for 100 ms every 5 s. B, representative traces of I Na in control oocytes or those treated with 30 or 100 M Rg 3 . Each oocyte was held at Ϫ50 or Ϫ100 mV and stepped to Ϫ10 mV for 100 ms every 5 s. C, left, histograms for the inhibition of I Na by 30 or 100 M DPH at different holding potentials. C, right, histograms for the inhibition of I Na by 30 or 100 M Rg 3 at different holding potentials. Data represent the means Ϯ S.E.M. (n ϭ 10 -11/ group). segment of domain II might play an important role in Rg 3 -induced use-dependent inhibition of the IFMQ3 mutant. These mutations also significantly increased the IC 50 values by 1.5-fold compared with wild-type in terms of tonic inhibition (*, P Ͻ 0.01, compared with wild-type; Table 1 ). It is noteworthy that lidocaine treatment produced wild-type level use-dependent inhibition in the K859Q mutant (Fig.  4C) , suggesting that the Rg 3 site is not related with the action of lidocaine. In contrast, when we examined whether the mutation in the S4 voltage-sensor segment of domain II affected Rg 3 -induced open-channel blocking pattern, we found that Rg 3 treatment inhibited both peak and plateau I Na levels to comparable degrees in the IFMQ3-K859Q and IFMQ3 mutants (compare Fig. 9, C and A) . The IC 50 values of the IFMQ3-K859Q mutant were 56 Ϯ 6 and 20 Ϯ 1 M for the peak and plateau I Na levels, respectively ( Fig. 9D and Table 1 ), which was significantly higher than that for the IFMQ3 mutant in terms of peak (1.5-fold) but not plateau I Na inhibition (**, P Ͻ 0.01, compared with IFMQ3 mutant, Table 1 ). These results indicate that the K859Q mutant might decrease the affinity of Rg 3 for the IFMQ3 mutant to a comparable degree as that seen in the wild-type but that the K859Q mutation did not affect the Rg 3 -induced open channel blocking pattern.
Developmental Rate of Rg 3 -Induced Open Channel Blockade. We examined the ability of various concentrations of Rg 3 to block IFMQ3 (Fig. 10A) . Untreated control traces showed that during a depolarizing pulse to Ϫ10 mV, the IMFQ3 current decayed exponentially with a single, slow time constant ( slow ) of 585.4 Ϯ 2.7 ms (n ϭ 9). Currents elicited after Rg 3 treatment decayed exponentially with two distinct time constants. In the presence of low concentration of Rg 3 (10 M), the currents decayed with a slow time constant that was similar to that of the control, whereas treatment with higher concentrations of Rg 3 such as 30 to 300 M induced a concentration-dependent fast exponential component to the curves ( fast ), which represented the Rg 3 block ( B ). The time constants of the fast components were 464.5 Ϯ 6.4, 235.1 Ϯ 7.8, 64.1 Ϯ 14.2, and 51.8 Ϯ 9.4 ms in samples treated with 10, 30, 100, and 300 M Rg 3 , respectively. This result indicates that Rg 3 also interacts with the open state of the Na ϩ channel. A plot of the reciprocal of B (1/ B ) against drug concentration (Lansman et al., 1986 ) was used to approximate the drug-channel interaction kinetics. The relationship between 1/ B and the concentration of Rg 3 was determined with a straight line representing the best fit to the equation 1/ B ϭ k on [Rg 3 ] ϩ l. (Fig. 10B) . The slope of the line is the apparent binding constant (k on ), which equals 0.062 Ϯ 0.009 ϫ 10 6 M Ϫ1 s Ϫ1 , and the intercept l equals 1.89 Ϯ 0.78 s Ϫ1 . The latter value is close to the reciprocal of slow (1.71 Ϯ 0.41 s Ϫ1 ), indicating that in the IFMQ3 mutant, a residual inactivation determines the intercept in the absence of Rg 3 . 
؉ Channels
This suggests that the unbinding constant (k off ) is likely to be very small. Rg 3 Treatment Slows Recovery from Inactivation. Because Rg 3 blocked the open state of the IFMQ3 channel (Fig. 9) and exhibited an additional use-dependent block compared with the wild-type channel (Fig. 4B) , we examined whether the inhibitory effect of Rg 3 on I Na was derived from a delayed recovery of the channel from the open channel block. Current traces were recorded in the absence (Fig. 10C , control, top) and presence (Fig. 10C, bottom) of 100 M Rg 3 with a recovery time interval of 10 ms between pulses. Recovery from open channel block was analyzed as shown in Fig. 10D . After a 10-ms prepulse (P1), recovery from open channel block was assessed using a test pulse (P2) after increasing recovery intervals (Fig. 10C and D, inset) . The IFMQ3 Na ϩ channels were found to recover rapidly, probably because of a slow inactivation associated with the mutation (Fig. 10D, Ͻ 50 ms, F) . In contrast, Rg 3 treated channels (Fig. 10D, E) showed a delayed recovery from open channel block (up to 260 ms). This slow recovery seems to underlie the enhanced use-dependent inhibition produced by Rg 3 .
Discussion
Ginseng has long been used as a treatment for a wide variety of ailments, and some of the purported effects of this root have been documented in laboratory studies (Nah, 1997) . Although the beneficial effects and functional mechanisms of ginsenosides have not been fully elucidated, accumulating evidence suggests that they may target the ion channels involved in neuronal excitability. Ginsenosides have been shown to affect several ion channels found at preand postsynaptic sites in the nervous system (Nah and McCleskey, 1994; Nah et al., 1995; Kim et al., 1998 Kim et al., , 2002 Choi et al., 2002 Choi et al., , 2003 Sala et al., 2002) , and their effects are closely coupled to the inhibition of neurotransmitter release (Tachikawa et al., 1995; Kudo et al., 1998) . We demonstrated recently that Rg 3 stereospecifically inhibits voltage-dependent brain Na ϩ currents and that the carbohydrate portion of Rg 3 plays a key role in the inhibition of Na ϩ currents (Kim et al., 2005) . However, very little is known about the molecular mechanism(s) underlying Rg 3 -induced Na ϩ channel modulation.
Herein, we characterized Rg 3 -induced channel regulation of brain Na ϩ channels (Na V 1.2) expressed in X. laevis oocytes. Our results revealed four major findings. First, Rg 3 produced a tonic inhibition of the peak I Na via an interaction with the resting state of the Na ϩ channel (Fig. 2) . Second, Rg 3 induced a large depolarizing shift in the steady-state activation of the Na ϩ channel (Fig. 3) . Third, Rg 3 produced a use-dependent block of the Na ϩ channel after high-frequency stimulation, indicating that Rg 3 could exert an inhibitory effect on the open state of the Na ϩ channel (Fig. 4) . Fourth, the inhibitory effect of Rg 3 on the peak I Na was independent of the holding potential, indicating that Rg 3 might have a Table 1 . lower affinity for the inactivated state of the Na ϩ channel (Fig. 5) .
To examine the molecular mechanism by which Rg 3 regulates brain Na ϩ channel activity, we used site-directed mutagenic methods similar to those previously used to identify drug-or toxin-Na ϩ channel interaction site(s) (Cestele and Catterall, 2000) . We used six different types of Na V 1.2 mutants to assess the sites at which Rg 3 interacts with Na ϩ channels: 1) mutations in the channel pore entrance of the S6 segment of domain I; 2) mutations in the pore region of domain II; 3) mutations in the lidocaine binding sites; 4) mutations in the TTX binding sites; 5) mutations in the S4 voltage-sensor segments of domains I, II, III, and IV; and 6) mutations in the inactivation cluster. The pore site(s) are unlikely to be the target for Rg 3 , because the inhibitory potency of Rg 3 on Na ϩ channel activity was not altered in cells injected with pore site mutants ( Fig. 7 and Table 1 ). In addition, it does not seem as though Rg 3 interacts with the binding sites for lidocaine or TTX (Ragsdale et al., 1994 (Ragsdale et al., , 1996 , because the inhibitory potency of Rg 3 on Na ϩ channel activity was not altered in cells injected with the F385C, F385S, F385Y, F385T, F385M, E387G, E387T, E387Q, F1764A, Y1771A, or F1764A-Y1771A mutants, which harbor changes in the lidocaine or TTX binding sites (Fig. 7 and Table 1 ). In addition, the inhibitory effect of Rg 3 on the peak I Na seemed additive in the presence of lidocaine or TTX in occlusion experiments (Fig. 6, C and D) , providing further evidence that Rg 3 uses a separate binding site. Finally, we tested the possibility that the hydrophobic cluster related with Na ϩ channel inactivation might be involved in the Rg 3 -induced inhibition of I Na . In the IFMQ3 mutant channel, which lacks fast inactivation (West et al., 1992) , Rg 3 treatment inhibited the noninactivating plateau I Na to a greater degree than the peak I Na , providing further evidences that Rg 3 inhibits I Na in both the open and resting states of the Na ϩ channel. Two other lines of evidence that support the possibility that Rg 3 also inhibits open Na ϩ channels are the observations that 1) the inhibitory effect of Rg 3 on peak I Na is not dependent on membrane holding potentials and 2) Rg 3 does not shift the steady-state inactivation curve in wild-type Na ϩ channels (Figs. 3 and 5) , which does occur in many drugs (e.g., antiarrhythmic agents and anticonvulsants) that act on inactivated Na ϩ channels (Willow et al., 1985) . Moreover, Rg 3 treatment induced an additional use-dependent block of I Na in the IFMQ3 mutant compared with wild-type channel, indicating that Rg 3 might prefer to bind and block the open state of the Na ϩ channel. Similar use-dependent open channel blockades have been observed in the case of disopyramide, RSD921, tetracaine, and flecainide (Cahalan, 1978; Grant et al., 1996; Pugsley and Goldin, 1999; Wang et al., 2003; Ramos and O'Leary, 2004) .
We next used S4 voltage-sensor segment mutants (K226Q, K859Q, R1312Q, and R1368Q) to examine whether the voltage-sensor segment of the Na ϩ channel was involved in Rg 3 -induced Na ϩ channel regulation (Noda et al., 1989) . The K859Q mutation in domain II, but not K226Q, R1312Q, or R1638Q, significantly increased the IC 50 values by 1.5-fold compared with wild-type (*, P Ͻ 0.01, compared with wildtype; Table 1 ), indicating that this mutation might decrease the affinity of Rg 3 to Na ϩ channels. In addition, K859Q alone abolished the Rg 3 -induced voltage shift in Na ϩ channel activation (Fig. 3C) and Rg 3 -induced use-dependent but not tonic inhibition of I Na (Figs. 4C and 7) . Although these results do not allow precise elucidation of the interaction between Rg 3 and Na ϩ channels, our data seem to indicate that the voltage-sensor S4 segment of domain II might be an important portion for Rg 3 -induced Na ϩ channel regulation (Figs. 3C  and 4C ). It is unlikely that Rg 3 interacts nonspecifically with Na ϩ channels, because the 20(S)-ginsenoside Rg 3 used in the present study inhibits I Na but 20(R)-ginsenoside Rg 3 does not (Jeong et al., 2004) (Fig. 1) . Moreover, modifications of the hydrophilic portion of Rg 3 by opening the cyclic glucoses or conjugating the glucoses with other hydrophobic molecule abolished the inhibitory effect of Rg 3 on peak I Na (Kim et al., 2005) . These findings indicate that Rg 3 specifically modulates Na ϩ channel by interaction with unidentified site of Na ϩ channel. Further works will be necessary to determine specific interaction site(s) of Rg 3 with Na ϩ channel. Based on our findings, it seems reasonable to speculate as Fig. 9 . The effects of Rg 3 on IFMQ3 mutant Na ϩ channels. The IFMQ3 mutant was constructed as described under Experimental Procedures. A, I Na was elicited in IFMQ3 mutant by a 500-ms depolarization to Ϫ10 mV from a holding potential of Ϫ100 mV, evoked every 5 s. The evoked current exhibited a slower decay and sizable persistent noninactivating or plateau current. Rg 3 treatment dose dependently inhibited the peak and plateau I Na values. B, concentration-response curves for the effect of Rg 3 on the IFMQ3 peak (F) and plateau (E) I Na values. The solid lines were fit by the Hill equation. C, current traces of the IFMQ3-K859Q mutant in the absence or presence of Rg 3 were obtained from the procedures described in A. D, concentration-response curves for the effect of Rg 3 on IFMQ3-K859Q peak (F) and plateau (E) I Na values. The IC 50 , Hill coefficient, and V max values for Rg 3 in these mutants are presented in Table 1 . Data represent the means Ϯ S.E.M. (n ϭ 10 -11/group). to whether the in vitro Rg 3 -induced Na ϩ channel blockade could translate to in vivo pharmacological effects. Qian et al. (2005) and Xie et al. (2005) determined plasma concentration of Rg 3 after administration of Rg 3 via intravenous (5 mg/kg) or intragastric (10 mg/kg) routes in rats and found that plasma Rg 3 peaked at 1 g/ml 10 min after intravenous administration and 4 h after intragastric administration. These findings suggest that plasma-borne Rg 3 might exert in vivo pharmacological effects. In addition, in rats, Bae et al. (2004) and Tian et al. (2005) showed that oral (100 mg/kg) or intravenous administration (5 and 10 mg/kg) of Rg 3 exerted significant neuroprotective effects against focal cerebral ischemic injury by decreasing neurological deficit scores and reducing the infarct area compared with the control group. Rg 3 also significantly improved mitochondrial energy metabolism, antagonized decreases in superoxide dismutase and glutathione-peroxidase activities, and increased malondialdehyde levels in a cerebral ischemia model (Tian et al., 2005) . Na ϩ channel-blocking drugs such as local anesthetics, antiarrhythmics, and anticonvulsants have been shown to exhibit significant neuroprotective effects against cerebral ischemia-, hypoxia-, and head trauma-induced neuronal damages (Taylor and Meldrum, 1995) . Thus, it is possible that Rg 3 -mediated brain I Na inhibition could be an underlying mechanism for neuroprotection against in vivo ischemic brain injury.
We demonstrated previously that Rg 3 and other ginsenosides inhibit voltage-dependent Ca 2ϩ and K ϩ channels as well as ligand-gated ion channels such as 5-HT 3 and some subsets of nicotinic acetylcholine receptors (Nah et al., 1995; Choi et al., 2002 Choi et al., , 2003 Jeong et al., 2004) . We are currently examining the detailed characteristics of Rg 3 -mediated regulation of Ca 2ϩ , K ϩ , and ligand-gated ion channels. The elucidation of the regulatory modes and identification of interaction site(s) with those channels or receptors by Rg 3 and other ginsenosides will provide important insights into the molecular basis by which ginsenosides interact with membrane proteins such as ion channels and receptors.
In this study, we used brain Na ϩ channel gene expression in a X. laevis oocyte model system to show that Rg 3 blocks the resting and open state of brain Na ϩ channels. This novel work provides new insights into one possible mechanism underlying the effects of ginsenosides in the nervous system. Shown is a representative pair of current traces recorded in the absence (Con, top) and presence (Rg 3 , bottom) of 100 M Rg 3 with a recovery time interval of 10 ms between pulses. Channels recovered almost fully at this recovery interval in the absence of Rg 3 . In the presence of 100 M Rg 3 , the test current measured during the second pulse (P2) was significantly reduced. D, recovery from inactivation or open channel blockade was assessed in detail using the paired-pulse voltageclamp protocol shown in the inset. After oocytes were depolarized for 10 ms (P1), fractional recovery during a subsequent test pulse (P2) was assessed after an intervening recovery interval. Rg 3 (F)-free channels recovered rapidly (Ͻ50 ms), whereas complete recovery from inactivation was delayed for 260 ms in the presence of Rg 3 (E). Data represent the means Ϯ S.E.M. (n ϭ 9 -10/group).
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